Stephens Inc’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $620K | Sell |
6,910
-424
| -6% | -$37.2K | 0.01% | 814 |
|
|
2026
Q1 | $690K | Buy |
7,334
+2,021
| +38% | +$185K | 0.01% | 756 |
|
|
2025
Q4 | $478K | Sell |
5,313
-1,564
| -23% | -$148K | 0.01% | 865 |
|
|
2025
Q3 | $677K | Sell |
6,877
-346
| -5% | -$34.3K | 0.01% | 756 |
|
|
2025
Q2 | $659K | Buy |
7,223
+1,158
| +19% | +$112K | 0.01% | 739 |
|
|
2025
Q1 | $686K | Sell |
6,065
-51
| -0.8% | -$5.46K | 0.01% | 709 |
|
|
2024
Q4 | $646K | Buy |
6,116
+202
| +3% | +$21.7K | 0.01% | 738 |
|
|
2024
Q3 | $638K | Buy |
+5,914
| New | +$645K | 0.01% | 744 |
|
|
2024
Q2 | – | Sell |
-1,672
| Closed | -$221K | – | 1362 |
|
|
2024
Q1 | $221K | Sell |
1,672
-235
| -12% | -$29.4K | ﹤0.01% | 1121 |
|
|
2023
Q4 | $232K | Sell |
1,907
-257
| -12% | -$28.7K | ﹤0.01% | 1026 |
|
|
2023
Q3 | $243K | Sell |
2,164
-490
| -18% | -$62.2K | ﹤0.01% | 969 |
|
|
2023
Q2 | $386K | Sell |
2,654
-1,175
| -31% | -$160K | 0.01% | 834 |
|
|
2023
Q1 | $495K | Sell |
3,829
-2,944
| -43% | -$370K | 0.01% | 718 |
|
|
2022
Q4 | $864K | Sell |
6,773
-4,999
| -42% | -$580K | 0.02% | 538 |
|
|
2022
Q3 | $1.23M | Sell |
11,772
-43,759
| -79% | -$4.8M | 0.03% | 478 |
|
|
2022
Q2 | $5.83M | Sell |
55,531
-19,189
| -26% | -$2.28M | 0.12% | 197 |
|
|
2022
Q1 | $9.56M | Buy |
74,720
+17,443
| +30% | +$2.1M | 0.16% | 145 |
|
|
2021
Q4 | $7.07M | Buy |
57,277
+44,149
| +336% | +$5.78M | 0.11% | 210 |
|
|
2021
Q3 | $1.87M | Buy |
13,128
+425
| +3% | +$62.5K | 0.03% | 481 |
|
|
2021
Q2 | $1.98M | Sell |
12,703
-14
| -0.1% | -$2.27K | 0.03% | 473 |
|
|
2021
Q1 | $1.98M | Sell |
12,717
-476
| -4% | -$73.7K | 0.03% | 458 |
|
|
2020
Q4 | $1.97M | Sell |
13,193
-804
| -6% | -$114K | 0.04% | 437 |
|
|
2020
Q3 | $1.85M | Sell |
13,997
-366
| -3% | -$47.8K | 0.04% | 400 |
|
|
2020
Q2 | $1.67M | Sell |
14,363
-921
| -6% | -$106K | 0.04% | 404 |
|
|
2020
Q1 | $1.5M | Buy |
15,284
+154
| +1% | +$20.2K | 0.04% | 396 |
|
|
2019
Q4 | $2.2M | Sell |
15,130
-904
| -6% | -$125K | 0.05% | 384 |
|
|
2019
Q3 | $2.14M | Sell |
16,034
-4,004
| -20% | -$517K | 0.05% | 373 |
|
|
2019
Q2 | $2.29M | Sell |
20,038
-6,590
| -25% | -$772K | 0.05% | 376 |
|
|
2019
Q1 | $3.3M | Sell |
26,628
-12,005
| -31% | -$1.36M | 0.08% | 290 |
|
|
2018
Q4 | $3.89M | Sell |
38,633
-4,666
| -11% | -$525K | 0.11% | 220 |
|
|
2018
Q3 | $5.53M | Sell |
43,299
-5,044
| -10% | -$600K | 0.14% | 177 |
|
|
2018
Q2 | $5.23M | Buy |
48,343
+2,916
| +6% | +$317K | 0.16% | 165 |
|
|
2018
Q1 | $4.81M | Buy |
45,427
+2,541
| +6% | +$295K | 0.18% | 148 |
|
|
2017
Q4 | $5.02M | Buy |
42,886
+2,725
| +7% | +$308K | 0.19% | 138 |
|
|
2017
Q3 | $4.57M | Buy |
40,161
+13,236
| +49% | +$1.53M | 0.16% | 135 |
|
|
2017
Q2 | $3.36M | Buy |
26,925
+8,706
| +48% | +$1.03M | 0.12% | 194 |
|
|
2017
Q1 | $2.16M | Buy |
+18,219
| New | +$2.06M | 0.08% | 266 |
|
|
2016
Q4 | – | Sell |
-2,301
| Closed | -$290K | – | 827 |
|
|
2016
Q3 | $290K | Sell |
2,301
-328
| -12% | -$40.5K | 0.01% | 620 |
|
|
2016
Q2 | $307K | Buy |
+2,629
| New | +$298K | 0.01% | 591 |
|
Other funds holding ZBH
Stephens Inc's ZBH Position: Q2 2026 in Review
Stephens Inc reduced its Zimmer Biomet (ZBH) stake by 5.8% in Q2 2026, selling an estimated $37.2K and leaving 6,910 shares worth $620K. The position accounts for 0.01% of the portfolio, ranked #814.
Stephens Inc first reported a position in ZBH in Q2 2016 and has held it in 39 quarters since. The position peaked at $9.56M in Q1 2022. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Stephens Inc held 6,910 shares of Zimmer Biomet worth $620K as of Q2 2026.
- Stephens Inc sold 424 Zimmer Biomet shares in Q2 2026, an estimated $37.2K.
- Zimmer Biomet made up 0.01% of Stephens Inc's portfolio in Q2 2026, its #814 holding.
- Stephens Inc first reported a position in Zimmer Biomet in Q2 2016 and has held it in 39 quarters since.
- Stephens Inc's Zimmer Biomet position peaked at $9.56M in Q1 2022.
- 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Stephens Inc's 13F filing for Q2 2026, filed 29 Jul 2026.